Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

Autor: Kieffer, Jacobien M., Postma, Tjeerd J., van de Poll-Franse, Lonneke, Mols, Floortje, Heimans, Jan J., Cavaletti, Guido, Aaronson, Neil K., Cavaletti, G., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Valsecchi, M. G., Galimberti, S., Rossi, E., Frigeni, B., Lanzani, F., Mattavelli, L., Piatti, M. L., Alberti, P., Binda, D., Bidoli, P., Cazzaniga, M., Cortinovis, D., Bruna, J., Velasco, R., Argyriou, A. A., Kalofonos, H. P., Psimaras, D., Ricard, D., Pace, A., Galiè, E., Briani, C., Lucchetta, M., Campagnolo, M., Torre, C. Dalla, Faber, C. G., Vanhoutte, E. K., Bakkers, M., Brouwer, B., Boogerd, M., Lalisang, R. I., Boogerd, W., Brandsma, D., Koeppen, S., Hense, J., Grant, R., Storey, D., Kerrigan, S., Schenone, A., Reni, L., Piras, B., Fabbri, S., Pessino, A., Padua, L., Granata, G., Leandri, M., Ghignotti, I., Plasmati, R., Pastorelli, F., Heimans, J. J., Eurelings, M., Meijer, R. J., Grisold, W., Pozza, E. Lindeck, Mazzeo, A., Toscano, A., Russo, M., Tomasello, C., Altavilla, G., Prado, M. Penas, Gonzalez, C. Dominguez, Dorsey, S. G.
Přispěvatelé: CCA - Cancer Treatment and quality of life, Neurology, Hense, Jörg (Beitragende*r), Psychology Other Research (FMG), Interne Geneeskunde, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Kieffer, J, Postma, T, van de Poll Franse, L, Mols, F, Heimans, J, Cavaletti, G, Aaronson, N, Cornblath, D, Merkies, I, Valsecchi, M, Galimberti, S, Rossi, E, Frigeni, B, Lanzani, F, Mattavelli, L, Piatti, M, Alberti, P, Binda, D, Bidoli, P, Cazzaniga, M, Cortinovis, D, Bruna, J, Velasco, R, Argyriou, A, Kalofonos, H, Psimaras, D, Ricard, D, Pace, A, Galiã¨, E, Briani, C, Lucchetta, M, Campagnolo, M, Torre, C, Faber, C, Vanhoutte, E, Bakkers, M, Brouwer, B, Boogerd, M, Lalisang, R, Boogerd, W, Brandsma, D, Koeppen, S, Hense, J, Grant, R, Storey, D, Kerrigan, S, Schenone, A, Reni, L, Piras, B, Fabbri, S, Pessino, A, Padua, L, Granata, G, Leandri, M, Ghignotti, I, Plasmati, R, Pastorelli, F, Eurelings, M, Meijer, R, Grisold, W, Pozza, E, Mazzeo, A, Toscano, A, Russo, M, Tomasello, C, Altavilla, G, Prado, M, Gonzalez, C, Dorsey, S
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
Oncology
Psychometrics
Colorectal cancer
Measurement model
Medizin
0302 clinical medicine
Quality of life
QUALITY-OF-LIFE
Surveys and Questionnaires
Scale structure
CRITERIA
Chemotherapy-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy
Factor analysis
Measurement model
Symptom checklist
Aged
Antineoplastic Agents
Female
Humans
Male
Middle Aged
Peripheral Nervous System Diseases
Psychometrics
Quality of Life
Surveys and Questionnaires

Peripheral Nervous System Diseases
Middle Aged
Exploratory factor analysis
Checklist
CAUSAL INDICATORS
030220 oncology & carcinogenesis
Factor analysis
Symptom checklist
Public Health
Environmental and Occupational Health

Female
Public Health
medicine.medical_specialty
Antineoplastic Agents
PATIENT
03 medical and health sciences
Internal medicine
medicine
MANAGEMENT
Humans
Aged
CANCER-TREATMENT
business.industry
Environmental and Occupational Health
Cancer
OUTCOME MEASURES
Factor analysi
medicine.disease
ONCOLOGY
NEUROTOXICITY
Quality of Life
Physical therapy
ADVERSE EVENTS
business
030217 neurology & neurosurgery
Settore MED/34 - MEDICINA FISICA E RIABILITATIVA
Zdroj: Kieffer, J M, Postma, T J, van de Poll-Franse, L, Mols, F, Heimans, J J, Cavaletti, G, Aaronson, N K, Postma, T J, Cavaletti, G, Postma, T J, Heimans, J J & In Collaboration with the CI-PeriNomS Group 2017, ' Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) ', Quality of Life Research, vol. 26, no. 11, pp. 2999-3010 . https://doi.org/10.1007/s11136-017-1626-1
Quality of Life Research, 26(11), 2999-3010. Springer Netherlands
Quality of Life Research, 26(11), 2999-3010. Springer
Quality of Life Research, 26(11), 2999-3010. Springer, Cham
ISSN: 0962-9343
DOI: 10.1007/s11136-017-1626-1
Popis: PURPOSE: To investigate the scale structure and psychometrics of the EORTC chemotherapy-induced peripheral neuropathy module (QLQ-CIPN20).METHODS: Using confirmatory factor analyses (CFA), we tested two hypothesized scale structure models of the QLQ-CIPN20 in 473 patients with non-small cell lung cancer, 281 patients with heterogeneous cancer diagnoses, and 500 patients with colorectal cancer. We also modeled the two hypothesized models as bi-factor models. These included a general factor, in addition to the specific domain factors. Additional models were investigated with exploratory factor analysis (EFA). Known groups validity was evaluated where justified.RESULTS: CFA could not confirm the two hypothesized models (Model 1: CFI < 0.926; TLI < 0.914; RMSEA > 0.077 and Model 2: CFI < 0.906; TLI < 0.887; RMSEA > 0.105) in any of the three samples. Including a general factor to these two hypothesized models to produce a bi-factor model also did not yield satisfactory results. Using EFA, we identified four different factor structures in the three samples that were unstable due to cross loadings of the items. When scoring the QLQ-CIPN20 as a simple, additive checklist evidence was found for known groups validity in the first two samples based on Common Toxicity Criteria (CTC-AE), and in the third sample based on exposure to CIPN-inducing chemotherapy.CONCLUSIONS: Neither CFA nor EFA yielded support for a stable subscale structure for the QLQ-CIPN20. Scoring the questionnaire as a simple additive checklist results in acceptable validity.
Databáze: OpenAIRE